Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Open-Label, Long-Term Extension Study of WA22762 and NA25220 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis

NCT01662063 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT01662063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01662063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Open-Label, Long-Term Extension Study of WA22762 and NA25220 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis
Lead sponsor
Genentech, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2012
Completion date
June 30, 2014
Enrollment
218 (actual)
Sites
79

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis